Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

被引：0
|
作者：
Teuber, G
Kallinowski, B
Niederau, C
Klinker, H
Galle, PR
Zankel, M
Zeuzem, S
机构：
[1] Med Klin 2, Frankfurt, Germany
[2] Innere Med 4, Heidelberg, Germany
[3] St Josef Hosp, Oberhausen, Germany
[4] Luitpold Krankenhaus, Wurzburg, Germany
[5] Med Klin 1, Mainz, Germany
[6] Essex Pharma, Munich, Germany
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
10.1016/S0168-8278(03)80873-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
607
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [31] Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin
    Bronowicki, Jean-Pierre
    Ouzan, Denis
    Asselah, Tarik
    Desmorat, Herve
    Zarski, Jean-Pierre
    Foucher, Juliette
    Bourliere, Marc
    Renou, Christophe
    Tran, Albert
    Melin, Pascal
    Hezode, Christophe
    Chevalier, Michelle
    Bouvier-Alias, Magali
    Chevaliez, Stephane
    Montestruc, Francois
    Lonjon-Domanec, Isabelle
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2006, 131 (04) : 1040 - 1048
  • [32] Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial
    Shehab, Hany M.
    Elbaz, Tamer M.
    Deraz, Dalia M.
    LIVER INTERNATIONAL, 2014, 34 (02) : 259 - 265
  • [33] Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatment
    Teuber, G
    Pascu, M
    Berg, T
    Lafrenz, M
    Weidenbach, H
    Schölmerich, J
    Wielzke-Braun, P
    Arnold, R
    Pausch, J
    Lock, G
    Junge, U
    Musch, E
    Zankel, M
    Hopf, U
    Zeuzem, S
    HEPATOLOGY, 2002, 36 (04) : 579A - 579A
  • [34] Retreatment of chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Vandelli, C
    Renzo, F
    Vecchi, C
    Lovato, E
    Tisminetzky, S
    Ventura, E
    JOURNAL OF HEPATOLOGY, 2000, 32 : 191 - 191
  • [35] Ribavirin plus human leucocyte interferon alpha for the treatment of interferon resistant chronic hepatitis C: A controlled trial
    Toccaceli, F
    Grimaldi, M
    Rosati, S
    Palazzini, E
    Laghi, V
    HEPATOLOGY RESEARCH, 1997, 8 (02) : 106 - 112
  • [36] Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatment
    Teuber, G
    Pascu, M
    Lafrenz, M
    Weidenbach, H
    Schoelmrich, J
    Wietzke-Braun, P
    Arnold, R
    Pausch, J
    Lock, G
    Zeuzem, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 132 - 132
  • [37] Efficacy and tolerability of recombinant interferon-alpha2b/ribavirin combination therapy for patients with chronic hepatitis C: Out-of-trial audit of first treatment and retreatment.
    Kumar, D
    Wallington-Beddoe, C
    George, J
    Lin, R
    Samarasinghe, D
    Liddle, C
    Farrell, G
    HEPATOLOGY, 2002, 36 (04) : 600A - 600A
  • [38] Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients
    Furusyo, N.
    Murata, M.
    Ogawa, E.
    Nomura, H.
    Hayashi, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S130 - S130
  • [39] The therapeutic effect of ribavirin plus pegylated interferon in chronic hepatitis B and C
    Chien, Rong-Nan
    Hu, Ching-Chih
    Sheen, I-Shyan
    Liaw, Yun-Fan
    Yen, Cho-Li
    Chang, Jia-Jang
    HEPATOLOGY, 2006, 44 (04) : 341A - 341A
  • [40] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
12345